← Return to Is anyone taking Ibrutinib (Imbruvica)?

Discussion

Is anyone taking Ibrutinib (Imbruvica)?

Blood Cancers & Disorders | Last Active: Sep 28, 2023 | Replies (18)
Comment receiving replies
@dottyk

Ibrutinib for refractory CNS DLBC transformed from Folicular.
Treatment with Rituximab, HD methotrexate and cytarabine added later successful peripherally achieving CR but didn't penetrate Blood brain barrier. Brain involvement remained stable. Have been commenced on Ibrutinib. Does anyone have experience with this.

Jump to this post

Replies to "Ibrutinib for refractory CNS DLBC transformed from Folicular. Treatment with Rituximab, HD methotrexate and cytarabine added..."
Colleen Young, Connect Director | @colleenyoung | Nov 23, 2022

Welcome, @dottyk.
I moved your question to this exisiting discussion about ibrutinib (Imbruvica) that @myla031 not that long ago. Please see:
- Is anyone taking Ibrutinib (Imbruvica)? https://connect.mayoclinic.org/discussion/is-anyone-taking-ibrutinib-for-marginal-zone-lymphoma/

I did this so you can read the previous posts and connect more easily with members like
@myla031 @betnlar @bullwinkle @kippi1950 @ejrquast.

VIEW AND REPLY